THE PHARMACEUTICAL Research and Manufacturers of America implicitly acknowledged the inappropriate influence of pharmaceutical gifts to our healthcare providers in choosing to revise their voluntary standards on gifts (" Drug industry tightens rules on gift-giving ," Page A1, July 11). Industry gifts to prescribers distort objectivity. We all pay the price in higher healthcare costs and compromised quality of care. (Full article: 211 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
